Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry.

Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry. Abstract Text:

Andreas H Ewald,Giselher Fritschi,Hans H Maurer,Andreas H Ewald,Giselher Fritschi,Hans H Maurer,

The amphetamine-derived designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) is an upcoming substance on the illicit drug market. In the current study, the identification of its metabolites in rat urine and their toxicological detection in the authors' systematic toxicological analysis (STA) procedure were examined. DOI is extensively metabolized by O-demethylation and beside small amounts of parent compound it was found to be excreted mainly in form of metabolites. The STA procedure using full-scan GC-MS allowed proving an intake of a common drug users' dose of DOI by detection of the two O-demethyl metabolite isomers in rat urine. Assuming similar metabolism, the described STA procedure should be suitable for proof of an intake of DOI in human urine.

Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry. Publishing Authors By Initials

AH Ewald,G Fritschi,HH Maurer,AH Ewald,G Fritschi,HH Maurer,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal of chromatography. B, Analytical technolog

VOLUME: 857

Page Numbers: 170-4

Journal Abbreviation: J. Chromatogr. B Analyt. Techn

ISSN: 1570-0232

DAY: 1

MONTH: 07

YEAR: 2007

Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101139554

Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry.

AFFILIATION: Department of Experimental and Clinical Toxicology, Institute of Experimental and Clinical Pharmacology and Toxicology, Saarland University, D-66421, Homburg (Saar), Germany.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Chromatogr B Analyt Technol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine DOI in rat urine using gas chromatography-mass spectrometry Related Publications

• Acquired cold urticaria symptoms can be safely prevented by ebastine.
• Adaptive Designs in Clinical Drug Development: Opportunities, Challenges, and Scope Reflections Following PhRMA's November 2006 Workshop.
• Assessing combinations of cytotoxic agents using leukemia cell lines.
• Cell-permeable peptides induce dose- and length-dependent cytotoxic effects.
• Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy.
• Do All Patients with Community-acquired Pneumonia Need Antibiotics Within 4 Hours of Presentation?
• Early detection of schizophrenia: current evidence and future perspectives.
• Egg labeling methods for gastric emptying scintigraphy are not equivalent in producing a stable solid meal.
• Employing mutants to study thrombin residues responsible for factor XIII activation peptide recognition: a kinetic study.
• Exposure of bovine embryos to trypsin during washing does not decrease embryonic survival.
• Highly Efficient Enzymatic Synthesis of 2-Monoacylglycerides and Structured Lipids and their Production on a Technical Scale.
• Improving state pain policies: recent progress and continuing opportunities.
• Information fusion in biomedical image analysis: combination of data vs. combination of interpretations.
• Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry.
• Modelling socioeconomic and health determinants of health-care use: a semiparametric approach.
• Nuclear medicine training for radiology residents: needs assessment survey.
• Oxybutynin for hyperhidrosis.
• Perturbations in factor XIII resulting from activation and inhibition examined by solution based methods and detected by MALDI-TOF MS.
• Platelet binding and biodistribution of [99mTc]rBitistatin in animal species and humans.
• Powerful short-cuts for multiple testing procedures with special reference to gatekeeping strategies.
• Preservation of microelastic properties of dentin and tooth enamel in vitro--a scanning acoustic microscopy study.
• Requestioning depression in patients with cancer: Contribution of somatic and affective symptoms to Beck's Depression Inventory.
• Retropubic surgery.
• Shape-based averaging.
• Superovulation and embryo quality in beef cows using PMSG and a monoclonal anti-PMSG.
• The complex morphology of Maurer's clefts: from discovery to three-dimensional reconstructions.
• Validated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-methoxym
• [In Process Citation]
• [Not Available.]
• [Not Available.]